US Cardiac Troponin Diagnostics Market, Forecast to 2021

High Prevalence of Heart Disease Propels Market Growth

USD 4,950.00

* Required Fields

USD 4,950.00

PAY BY INVOICE

Be the first to review this product

Cardiac troponins help to diagnose nearly two-thirds of the patients in the diagnosis Acute Coronary Syndrome (ACS) who are missed out by Echocardiogram (ECG). ECG can detect only one-third of the patients with persistent ST-segment Elevation (STEMI), whereas cardiac troponins can distinguish patients without ST-segment elevation (NSTEACS; non-ST segment elevation ACS) who require a conservative Unstable Angina (UA) or early-invasive approach (NSTEMI).In addition to significant pricing challenges, there is growing competition encouraged by the adoption of point-of-care devices at physician offices and hospitals. Although technicians and patients prefer point-of-care devices, physicians and hospitals are still s

Research Scope

The objective of this research is to establish an understanding of the market for cardiac biomarker Troponin used for the diagnosis of acute myocardial infarction. The research covers the revenue generated by the use of cardiac troponin tests for diagnosis of acute myocardial infarction.


Key Issues Addressed

  • What are the key healthcare trends that could impact the global cardiac biomarker diagnostics market?
  • What are the market drivers and restraints that are impacting market growth?
  • What are the unmet needs and opportunities for existing and emerging participants?
  • What are the segment shares of key market participants?
  • How are companies dealing with the challenges in the market space?
  • What are the future trends and how is the forecast scenario of Acute Myocardial infarction (AMI) biomarkers diagnostics in different regions?

Table of Contents

1. Executive Summary
Global Cardiac Troponin Market—Executive Summary
US Cardiac Troponins Market—Executive Summary
Western European Cardiac Troponins Market—Executive Summary
APAC Cardiac Troponins Market—Executive Summary
Scope and Segmentation
Market Engineering Measurements
Cardiac Diagnostics Industry Overview
Cardiac Biomarkers Diagnostics Overview
Executive Summary—3 Big Predictions
2. Forecasts and Discussion
Market Engineering Measurements
Forecast Methodology
Revenue Forecast
Percent Revenue Breakdown by Segment—Lab-based Tests Versus POCT
Revenue Forecast by Segment
Percent Revenue Forecast by Region
Revenue Forecast by Region
Percent of Revenue by Region
3. Competitive Environment
Market Share
Market Share Analysis
Top Competitors
4. Lab-based Tests Segment Analysis
Market Engineering Measurements
Revenue Forecast
Segment Share
Segment Share Analysis
5. POCT Segment Analysis
Market Engineering Measurements
Revenue Forecast
Segment Share
Segment Share Analysis
6. Regional Analysis—US
Executive Summary
Scope and Segmentation
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
7. Market Overview
Market Background
Market Background—Prevalence Rate
Market Overview—Testing Procedure
Current Trends in US Troponin Market
Troponin Testing Locations
8. Competitive Playbook
New Market Opportunities
Competitive Structures
Product Portfolio
9. Drivers and Restraints
Market Drivers
Market Restraints
10. Forecasts and Discussion
Key Findings
Forecast Methodology
Market Engineering Measurements
Revenue Forecast
Segment Breakdown
Revenue Forecast by Segment
US Lab-based Test Segment—Pricing Trends and Forecast
11. Competitive Environment
Market Share
Market Share Analysis
12. Growth Opportunity
Major Growth Opportunities
Growth Opportunity Matrix—Key Opportunities and Impact on Businesses
Growth Opportunity 1—Companion Diagnostics
Growth Opportunity 2—POCT in Cardiac Biomarker Diagnostics
Growth Opportunity 3—Integrated and Efficient System
Growth Opportunity 4—Digital Health and Diagnostics Inter- convergence Model
Strategic Imperatives for Success and Growth
13. Lab-based Segment Analysis
Key Findings
Market Engineering Measurements
Revenue Forecast
Market Share
Market Share Analysis
14. POCT Segment Analysis
Key Findings
Market Engineering Measurements
Revenue Forecast
Market Share
Market Share Analysis
15. The Last Word
The Last Word—3 Big Predictions
Legal Disclaimer
16. Appendix
Market Engineering Methodology
List of Other Companies in Biomarkers Research, Development, and/or Services
List of Exhibits

Infographic



List of Figures & Charts

1. Total Cardiac Troponin Diagnostics Market: Market Engineering Measurements, Global, 2016
2. Total Cardiac Troponin Diagnostics Market: Revenue Forecast by Region, Global, 2015–2021
3. Total Cardiac Troponin Diagnostics Market: Company Market Share Analysis of Top 5 Market Participants, Global, 2016
4. Total Cardiac Troponin Diagnostics Market: SWOT Analysis, Global, 2016
5. Lab-based Tests Segment: Market Engineering Measurements, Global, 2016
6. Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, Global, 2016
7. POCT Segment: Market Engineering Measurements, Global, 2016
8. POCT Segment: Company Segment Share Analysis of Top 4 Participants, Global, 2016
9. Cardiac Troponin Diagnostics Market: New Market Opportunities, US, 2016
10. Cardiac Troponin Diagnostics Market: Competitive Structure, US, 2016
11. Cardiac Troponin Diagnostics Market: Product Analysis, US, 2016
12. Cardiac Troponin Diagnostics Market: Key Market Drivers, US, 2017–2021
13. Cardiac Troponin Diagnostics Market: Key Market Restraints, US, 2017–2021
14. Cardiac Troponin Diagnostics Market: Market Engineering Measurements, US, 2016
15. Cardiac Troponin Diagnostics Market: Company Market Share Analysis of Top 7 Participants, US, 2016
16. Cardiac Troponin Diagnostics Market: Growth Opportunity Matrix, US, 2016
17. Lab-based Tests Segment: Market Engineering Measurements, US, 2016
18. Lab-based Tests Segment: Company Market Share Analysis of Top 4 Participants, US, 2016
19. POCT Segment: Market Engineering Measurements, US, 2016
20. POCT Segment: Company Market Share Analysis of Top 6 Participants, US, 2016


1. Total Cardiac Troponin Diagnostics Market: Market Engineering Measurements, Global, 2016
2. Total Cardiac Troponin Diagnostics Market: Industry Overview, Global, 2016
3. Total Cardiac Troponin Diagnostics Market: Market Overview, Global, 2016
4. Total Cardiac Troponin Diagnostics Market: Revenue Forecast, Global, 2015–2021
5. Total Cardiac Troponins Market: Percent Revenue by Segment, Global, 2016
6. Total Cardiac Troponins Market: Percent Revenue Forecast by Segment, Global, 2021
7. Total Cardiac Troponin Diagnostics Market: Revenue Forecast by Segment, Global, 2015–2021
8. Total Cardiac Troponin Diagnostics Market: Percent Revenue Forecast by Region, Global, 2015–2021
9. Total Cardiac Troponin Diagnostics Market: Percent of Revenue by Region, Global, 2016
10. Cardiac Troponin Lab-based Test Segment: Percent of Revenue by Region, Global, 2016
11. Cardiac Troponin POCT Segment: Percent of Revenue by Region, Global, 2016
12. Total Cardiac Troponin Diagnostics Market: Percent Revenue Breakdown, Global, 2016
13. Lab-based Tests Segment: Revenue Forecast, Global, 2015–2021
14. Lab-based Tests Segment: Percent Revenue Breakdown, Global, 2016
15. POCT Segment: Revenue Forecast, Global, 2015–2021
16. POCT Segment: Percent Revenue Breakdown, Global, 2016
17. Cardiac Troponin Diagnostics Market: Market Engineering Measurements, US, 2016
18. Cardiac Troponin Diagnostics Market: Prevalence Rate, US, 2009–2020
19. Laboratory Based Tests Segment: Testing Locations, US, 2016
20. POCT Based Tests Segment: Testing Locations, US, 2016
21. Cardiac Troponin Diagnostics Market: Percent Revenue Breakdown by Region, US, 2016
22. Cardiac Troponin Diagnostics Market: Revenue Forecast, US, 2015–2021
23. Cardiac Troponin Diagnostics Market: Market Segmentation, US, 2016
24. Cardiac Troponin Diagnostics Market: Market Segmentation Forecast, US, 2021
25. Cardiac Troponin Diagnostics Market: Revenue Forecast by Segment, US, 2015–2021
26. Lab-based Test Segment: Average Price for Lab-based Tests, US, 2015–2021
27. Cardiac Troponin Diagnostics Market: Percent Revenue Breakdown, US, 2016
28. Cardiac Troponin Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2016
29. Lab-based Tests Segment: Revenue Forecast, US, 2015–2021
30. Lab-based Tests Segment: Percent Revenue Breakdown, US, 2016
31. Cardiac Troponin Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2016
32. POCT Segment: Revenue Forecast, US, 2015–2021
33. POCT Segment: Percent Revenue Breakdown, US, 2016



Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.